☆ 4.6 Article

Detection of metastases using circulating tumour DNA in uveal melanoma

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Ophthalmology

Incidence and mortality of uveal melanoma in Australia (1982-2014)

Aaron B. Beasley et al.

Summary: This study aimed to estimate the incidence and mortality of uveal melanoma (UM) in Australia from 1982 to 2014. The results showed that the incidence of UM peaked in the 1990s and did not significantly change in the last 30 years. Age, residence, and histological classification were significantly associated with survival among UM patients.

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

添加到收藏夹

Article Surgery

Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma

Pascale Mariani et al.

Summary: This study reports the detection rate and prognostic impact of circulating tumor DNA in patients undergoing surgical resection of liver metastases in uveal melanoma. If confirmed by further studies, this noninvasive biomarker could inform treatment decisions for liver metastases in uveal melanoma patients.

ANNALS OF SURGERY (2023)

添加到收藏夹

Article Oncology

Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

Derek Wong et al.

Summary: Uveal melanomas are rare eye tumors with a high risk of metastasis to the liver. This study used cfDNA sequencing to analyze samples from uveal melanoma patients, and found that integrated analysis using different techniques improved the detection of relapse. The fragmentomic profiles showed the highest predictive power. This work supports the use of multi-modal cfDNA sequencing for sensitive detection of circulating tumor DNA.

CANCER RESEARCH COMMUNICATIONS (2023)

添加到收藏夹

Review Oncology

Future perspectives of uveal melanoma blood based biomarkers

Aaron B. Beasley et al.

Summary: Uveal melanoma is the most common primary intraocular malignancy, and despite successful local treatment, the risk of metastatic disease remains. Intraocular tumor biopsy is the current prognostic method, but it is invasive and limited by sampling variability. Liquid biopsy, including circulating tumor cells, circulating tumor DNA, microRNA, and exosomes, holds great potential for minimally invasive genetic characterization of tumors.

BRITISH JOURNAL OF CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma

Daniel P. de Bruyn et al.

Summary: Uveal melanoma, the second most common type of melanoma, is often treated with minimally invasive techniques. However, the lack of tumor material hinders molecular analysis. Blood-based biomarker analysis has gained popularity, but standardization is lacking. This review highlights new insights in biomarker analysis and emphasizes the importance of medical imaging in UM.

BIOMEDICINES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

Richard D. Carvajal et al.

Summary: In a study of previously treated metastatic uveal melanoma patients, treatment with Tebentafusp showed promising clinical activity and acceptable safety profile. Early reduction in circulating tumor DNA was strongly associated with overall survival.

NATURE MEDICINE (2022)

添加到收藏夹

Article Ophthalmology

Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma

Jasmine H. Francis et al.

Summary: This study aims to investigate the presence of plasma circulating tumor DNA (ctDNA) in patients with uveal melanoma during and after primary tumor treatment. The study found that ctDNA was significantly more detectable at 48 to 72 hours after plaque brachytherapy compared with less than 48 hours, and ctDNA can also be detected during enucleation. Relative increases in ctDNA levels may herald the development of clinically apparent metastases.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing

Weitao Lin et al.

Summary: Tumor heterogeneity is a major obstacle to the success of cancer treatment, and an accurate understanding and recognition of tumor heterogeneity is critical.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2021)

添加到收藏夹

Article Oncology

Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

Jose Maria Piulats et al.

Summary: The combination of nivolumab and ipilimumab as first-line therapy for metastatic uveal melanoma patients showed a modest improvement in 12-month overall survival, with manageable toxicity profile.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Meeting Abstract Oncology

Early reduction in ctDNA, regardless of best RECIST response, is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma (mUM) patients

A. N. Shoushtari et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan et al.

Summary: The randomized trial of tebentafusp for metastatic uveal melanoma showed a higher 1-year overall survival rate among patients who received tebentafusp compared to those who received the investigator's choice of therapy, indicating superior efficacy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

Lars Ny et al.

Summary: The combination of HDAC inhibitor entinostat with anti-PD-1 antibody pembrolizumab shows durable responses in a subset of patients with metastatic uveal melanoma. Factors such as wildtype BAP1 gene, low tumor burden, and iris melanoma may be associated with better treatment response and longer survival.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Early detection of metastatic uveal melanoma by the analysis of tumor-specific mutations in cell-free plasma DNA

Claudia H. D. Le Guin et al.

Summary: The study found that detecting ctDNA signals in the plasma of patients with uveal melanoma could provide a time advantage over clinical diagnosis of metastases or tumor recurrence, and longer lead times are expected with shortened intervals between samplings.

CANCER MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

Michael A. Durante et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

Peter A. Johansson et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular profiling of driver events in metastatic uveal melanoma

Joakim Karlsson et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Oncology

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Yana G. Najjar et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Cell Biology

Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics

Ariana Rostami et al.

CELL REPORTS (2020)

添加到收藏夹

Article Oncology

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Ernesto Rossi et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

添加到收藏夹

Article Oncology

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma

Leslie Calapre et al.

MOLECULAR ONCOLOGY (2019)

添加到收藏夹

Article

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies

Ashleigh C. McEvoy et al.

Oncotarget (2019)

添加到收藏夹

Article Pathology

Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma

Kyra N. Smit et al.

MODERN PATHOLOGY (2018)

添加到收藏夹

Review Oncology

Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review

Markus V. Heppt et al.

CANCER TREATMENT REVIEWS (2017)

添加到收藏夹

Article Oncology

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

L. Cabel et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

J. H. Lee et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Ophthalmology

Survival from uveal melanoma in Western Australia 1981-2005

Avenell L. Chew et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

添加到收藏夹

Article Oncology

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

Elin S. Gray et al.

ONCOTARGET (2015)

添加到收藏夹

Article Oncology

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform

Evelyn Kidess et al.

ONCOTARGET (2015)

添加到收藏夹

Article Oncology

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma

Francois-Clement Bidard et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

添加到收藏夹

Article Oncology

Surgical management of liver metastases from uveal melanoma: 1.6 years' experience at the Institut Curie

P. Mariani et al.

EJSO (2009)

添加到收藏夹

Article Ophthalmology

Incidence of uveal melanoma in Europe

Gianni Virgili et al.

OPHTHALMOLOGY (2007)

添加到收藏夹

Article Ophthalmology

Whole body PET/CT for initial staging of choroidal melanoma

PT Finger et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2005)

添加到收藏夹

Article Ophthalmology

Very long-term prognosis of patients with malignant uveal melanoma

E Kujala et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.